IBDEI1N7 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26231,1,3,0)
 ;;=3^Antibiotics
 ;;^UTILITY(U,$J,358.3,26231,1,4,0)
 ;;=4^Z79.2
 ;;^UTILITY(U,$J,358.3,26231,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,26232,0)
 ;;=Z79.01^^107^1232^2
 ;;^UTILITY(U,$J,358.3,26232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26232,1,3,0)
 ;;=3^Anticoagulants
 ;;^UTILITY(U,$J,358.3,26232,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,26232,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,26233,0)
 ;;=Z79.02^^107^1232^3
 ;;^UTILITY(U,$J,358.3,26233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26233,1,3,0)
 ;;=3^Antiplatelets/Antithrombotics
 ;;^UTILITY(U,$J,358.3,26233,1,4,0)
 ;;=4^Z79.02
 ;;^UTILITY(U,$J,358.3,26233,2)
 ;;=^5063331
 ;;^UTILITY(U,$J,358.3,26234,0)
 ;;=Z79.82^^107^1232^4
 ;;^UTILITY(U,$J,358.3,26234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26234,1,3,0)
 ;;=3^Aspirin
 ;;^UTILITY(U,$J,358.3,26234,1,4,0)
 ;;=4^Z79.82
 ;;^UTILITY(U,$J,358.3,26234,2)
 ;;=^5063340
 ;;^UTILITY(U,$J,358.3,26235,0)
 ;;=Z79.4^^107^1232^6
 ;;^UTILITY(U,$J,358.3,26235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26235,1,3,0)
 ;;=3^Insulin
 ;;^UTILITY(U,$J,358.3,26235,1,4,0)
 ;;=4^Z79.4
 ;;^UTILITY(U,$J,358.3,26235,2)
 ;;=^5063334
 ;;^UTILITY(U,$J,358.3,26236,0)
 ;;=Z79.1^^107^1232^9
 ;;^UTILITY(U,$J,358.3,26236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26236,1,3,0)
 ;;=3^NSAID
 ;;^UTILITY(U,$J,358.3,26236,1,4,0)
 ;;=4^Z79.1
 ;;^UTILITY(U,$J,358.3,26236,2)
 ;;=^5063332
 ;;^UTILITY(U,$J,358.3,26237,0)
 ;;=Z79.891^^107^1232^8
 ;;^UTILITY(U,$J,358.3,26237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26237,1,3,0)
 ;;=3^Long Term Opiate/Opioid Analgesic Use
 ;;^UTILITY(U,$J,358.3,26237,1,4,0)
 ;;=4^Z79.891
 ;;^UTILITY(U,$J,358.3,26237,2)
 ;;=^5063342
 ;;^UTILITY(U,$J,358.3,26238,0)
 ;;=Z79.51^^107^1232^5
 ;;^UTILITY(U,$J,358.3,26238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26238,1,3,0)
 ;;=3^Inhaled Steroids
 ;;^UTILITY(U,$J,358.3,26238,1,4,0)
 ;;=4^Z79.51
 ;;^UTILITY(U,$J,358.3,26238,2)
 ;;=^5063335
 ;;^UTILITY(U,$J,358.3,26239,0)
 ;;=Z79.52^^107^1232^11
 ;;^UTILITY(U,$J,358.3,26239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26239,1,3,0)
 ;;=3^Steroids-Systemic
 ;;^UTILITY(U,$J,358.3,26239,1,4,0)
 ;;=4^Z79.52
 ;;^UTILITY(U,$J,358.3,26239,2)
 ;;=^5063336
 ;;^UTILITY(U,$J,358.3,26240,0)
 ;;=Z79.899^^107^1232^7
 ;;^UTILITY(U,$J,358.3,26240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26240,1,3,0)
 ;;=3^Long Term Current Drug Therapy NEC
 ;;^UTILITY(U,$J,358.3,26240,1,4,0)
 ;;=4^Z79.899
 ;;^UTILITY(U,$J,358.3,26240,2)
 ;;=^5063343
 ;;^UTILITY(U,$J,358.3,26241,0)
 ;;=Z79.84^^107^1232^10
 ;;^UTILITY(U,$J,358.3,26241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26241,1,3,0)
 ;;=3^Oral Hypoglycemic Drugs
 ;;^UTILITY(U,$J,358.3,26241,1,4,0)
 ;;=4^Z79.84
 ;;^UTILITY(U,$J,358.3,26241,2)
 ;;=^5140432
 ;;^UTILITY(U,$J,358.3,26242,0)
 ;;=Z90.13^^107^1233^5
 ;;^UTILITY(U,$J,358.3,26242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26242,1,3,0)
 ;;=3^Acquired Absence of Breasts & Nipples,Bilateral
 ;;^UTILITY(U,$J,358.3,26242,1,4,0)
 ;;=4^Z90.13
 ;;^UTILITY(U,$J,358.3,26242,2)
 ;;=^5063584
 ;;^UTILITY(U,$J,358.3,26243,0)
 ;;=Z90.710^^107^1233^6
 ;;^UTILITY(U,$J,358.3,26243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26243,1,3,0)
 ;;=3^Acquired Absence of Cervix & Uterus
 ;;^UTILITY(U,$J,358.3,26243,1,4,0)
 ;;=4^Z90.710
 ;;^UTILITY(U,$J,358.3,26243,2)
 ;;=^5063591
 ;;^UTILITY(U,$J,358.3,26244,0)
 ;;=Z90.712^^107^1233^7
